Regeneron Pharmaceuticals, Inc. (REGN) — Analyst estimates
Consensus analyst estimates for Regeneron Pharmaceuticals, Inc. — earnings, revenue, and price targets.
| Fiscal Year | Revenue Forecast | EPS Forecast | analysts |
|---|---|---|---|
| 2026 | 4.35B | 13.06 | 10 |
| 2027 | 5.05B | 17.26 | 6 |
| 2028 | 18.92B | 60.88 | 8 |
| 2029 | 20.97B | 72.07 | 6 |
| 2030 | 21.46B | 71.47 | 6 |
Consensus analyst estimates by fiscal year.